Helsinn's leading position in its main business areas, Anti-inflammatory, Oncology and Supportive Care, Gastrointestinal, is reflected by the presence of the group's products in over 75 countries and over 60 partners, such as

ACHE - ANEID - ANGELINI - ATCO - BIOGENED - BIOMEKS - BIOTOSCANA - BIOVITRUM -BOEHRINGER INGELHEIM - CAMBRIDGE - CHOONGWAE - CJ CORP. - CSC - EKR - ERGHA - ERGO MAROC - EVOLABIS - FIDIA - GALENICA - GRUENENTHAL - GSK - HARVESTER/HOLLING - HELIX - HELSINN BIREX THERAPEUTICS - HIKMA - ITALFARMACO - KALBE - LABORATORIOS RUBIO - LAVIPHARM - MANTECORP - MGI PHARMA - NORGINE - NOVAMED - NOVARTIS - ONKO & KOÇSEL - ORPHAN - PHARMASWISS - P.N. GEROLYMATOS - P.T. GALA - PFIZER - PROCONCEPTA - QUALITY PHARMA - RAFA - RIBOSEPHARM - ROBAPHARM - ROCHE - SANOFI AVENTIS - SCHERING-PLOUGH - SIGMA-TAU - SILESIA - SULKAJ - TAIHO - TEVA TUTEUR - THERABEL - TRAMEDICO - UCB - VIFOR - VIRBAC